Mitoxantrone-cyclophosphamide-rituximab: an effective and safe combination for indolent NHL

This publication has 6 references indexed in Scilit:

• Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
  Blood, 2000
• CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation
  Blood, 2000
• Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies
  Blood, 1998
• IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
  Blood, 1997
• Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
  Blood, 1994
• Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma
  Blood, 1977